Betahistine DihydrochlorideThird Party Manufacturing in India

Betahistine Dihydrochloride works by acting as a strong antagonist at histamine H3 receptors and a weak agonist at histamine H1 receptors in the nervous system to improve inner ear microcirculation.

By blocking presynaptic histamine H3 receptors, Betahistine increases the release of endogenous histamine and other neurotransmitters in the inner ear. At the same time, its agonist activity at postsynaptic H1 receptors induces local vasodilation in the inner ear. This dual action increases blood flow in the stria vascularis and capillary bed of the cochlea and vestibular system. It also reduces endolymphatic pressure (hydrops) and dampens the firing rate of vestibular neurons, which helps stabilize sensory inputs.

Unlike traditional antihistamines that cause drowsiness, Betahistine Dihydrochloride is non-sedating and promotes vestibular compensation to restore balance. It is highly effective and well-tolerated for the management of vertigo and tinnitus associated with Meniere's disease.

Therapeutic Uses

Betahistine Dihydrochloride is prescribed for the treatment of:

• Meniere's Disease: Manages the core triad of symptoms: vertigo, tinnitus (ringing in the ears), and progressive hearing loss.
• Vestibular Vertigo: Relieves spinning sensations and dizziness caused by inner ear vestibular system disorders.
• Tinnitus: Reduces persistent ringing or buzzing sounds in the ears associated with labyrinthine disturbances.
• Peripheral Vertigo: Used to treat dizziness of peripheral origin in adults.

Why Manufacturers Choose Betahistine Dihydrochloride

Betahistine Dihydrochloride is a highly stable, high-demand molecule in the ENT and neurology segments. Vertigo and balance disorders affect a large percentage of the aging population, ensuring a consistent and growing market.

For third party manufacturing in India, Betahistine represents a core product for companies with strong tableting capabilities. Because vertigo treatment requires long-term therapy, patient compliance is highly dependent on formulation quality and the absence of side effects. Sourcing Betahistine tablets from WHO-GMP certified facilities ensures precise active ingredient distribution across lower strengths (like 8mg, 16mg, and 24mg) and uniform dissolution profiles. This high level of quality control is essential for secure registration in export markets and establishing a strong brand reputation domestically.

This makes Betahistine Dihydrochloride one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.